Drugs / Advax-3(TM)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01951677 | Jul 2013 → Oct 2017 | hepatitis B virus infection | Vaxine Pty Ltd | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Advax-3(TM) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01951677 ↗ |